June 24, 2020 / 12:39 PM / 12 days ago

BRIEF-GBT Announces Plans To Seek Regulatory Approval For Oxbryta To Treat Sickle Cell Patients In Europe

June 24 (Reuters) - Global Blood Therapeutics Inc:

* GBT ANNOUNCES PLANS TO SEEK REGULATORY APPROVAL FOR OXBRYTA® (VOXELOTOR) TO TREAT SICKLE CELL PATIENTS IN EUROPE

* GLOBAL BLOOD THERAPEUTICS - MARKETING AUTHORIZATION APPLICATION SUBMISSION PLANNED BY MID-2021

* GLOBAL BLOOD THERAPEUTICS INC - ALSO INTENDS TO INITIATE AN EARLY ACCESS PROGRAM IN EUROPE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below